In a subsequent report, loss of insulin secretory capacity was the primary event leading to hemochromatosis-related diabetes in thirty nonscreening patients with hemochromatosis (26 p.C282Y homozygotes) and mean SF 1501 ± 287 (standard deviation) ng/mL [1]. This evidence concerns the gene INS and hemochromatosis type 1.